M&T Bank
OCUL icon

M&T Bank’s Ocular Therapeutix OCUL Stock Holding History

M&T Bank’s Portfolio OCUL Stock Details OCUL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$90.4K Buy
+10,671
New +$102K ﹤0.01% 1637

Other funds holding OCUL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
SR
Summer Road West Palm Beach, Florida $142M AUM 43.61% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

M&T Bank's OCUL Position: Q1 2026 in Review

M&T Bank opened a new position in Ocular Therapeutix (OCUL) in Q1 2026: 10,671 shares worth $90.4K. The stake represents ﹤0.01% of the portfolio and ranks #1637 among its holdings.

269 funds tracked by Wall St. Rank hold OCUL as of Q1 2026.

  • M&T Bank held 10,671 shares of Ocular Therapeutix worth $90.4K as of Q1 2026.
  • Ocular Therapeutix was a new M&T Bank position in Q1 2026.
  • Ocular Therapeutix made up ﹤0.01% of M&T Bank's portfolio in Q1 2026, its #1637 holding.
  • 269 funds tracked by Wall St. Rank held Ocular Therapeutix as of Q1 2026.

Based on M&T Bank's 13F filing for Q1 2026, filed 12 May 2026.